Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XDD.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HW.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GE.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCHNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JF.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCKNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDCNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.15.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JR.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JG.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.86.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.22.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HW.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.46NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GB.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.72NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.86NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.41.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.4.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JF.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JG.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBBNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used